De-escalation of elective radiotherapy guided by FDG-PET lowers modeled late swallowing-related toxicity in head and neck cancer.

Saved in:
Bibliographic Details
Title: De-escalation of elective radiotherapy guided by FDG-PET lowers modeled late swallowing-related toxicity in head and neck cancer.
Authors: Stritzke F; Heidelberg University, Heidelberg Faculty of Medicine, Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany., Dvornikovich K; Heidelberg University, Heidelberg Faculty of Medicine, Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany., Lau H; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany., Tessonnier T; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany., Schröter P; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany., Neugebauer D; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany., Netzer N; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany., Bauer L; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany., Thölken R; Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany., Winter E; Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany., Harrabi S; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany., Mairani A; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany., Haberkorn U; Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany., Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany.; German Cancer Consortium (DKTK), partner site Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany., Held T; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany.; German Cancer Consortium (DKTK), partner site Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Source: Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2026 Apr 01; Vol. 59, pp. 101156. Date of Electronic Publication: 2026 Apr 01 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ireland Ltd. on behalf of European Society for Radiotherapy and Oncology Country of Publication: Ireland NLM ID: 101713416 Publication Model: eCollection Cited Medium: Internet ISSN: 2405-6308 (Electronic) Linking ISSN: 24056308 NLM ISO Abbreviation: Clin Transl Radiat Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2405-6308
DOI:10.1016/j.ctro.2026.101156